recombinant human interleukin-21
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant human interleukin-21, covering 2017-03-01 to 2017-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients [Phase 2]